Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.29% is 57% below its 5-year average of 0.67%, near the low end of its 5-year range (0.00%–1.05%).
As of the fiscal period ended Tuesday, June 30, 2026. 30.69% below its 12-month average of 0.42%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.29%.
DEBT TO ASSETS RATIO
0.29%
DEBT TO ASSETS RATIO AVG TTM
0.42%
DEBT TO ASSETS RATIO AVG 3Y
0.58%
DEBT TO ASSETS RATIO AVG 5Y
0.67%
DEBT TO ASSETS RATIO AVG 10Y
0.47%
DEBT TO ASSETS RATIO AVG 15Y
0.34%
DEBT TO ASSETS RATIO AVG 20Y
0.28%
CURRENT VS TTM AVG
-30.69%
CURRENT VS 3Y AVG
-49.66%
CURRENT VS 5Y AVG
-56.63%
CURRENT VS 10Y AVG
-37.92%
CURRENT VS 15Y AVG
-14.04%
CURRENT VS 20Y AVG
+3.47%
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
+221.62%
vs the sector median at left
MediciNova, Inc.
Market Cap
$81.22M
Debt to Assets Ratio
0.29%
TTM Avg
0.42%
3Y Avg
0.58%
5Y Avg
0.67%
Market Cap
$82.47M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$82.53M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$82.59M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$79.61M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$79.03M
Debt to Assets Ratio
0.09%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MediciNova, Inc. (MNOV) | $81.22M | 0.29% | 0.42% | 0.58% | 0.67% |
| Nutriband Inc. (NTRB)vs › | $81.20M | 0.03% | N/A | N/A | N/A |
| Humacyte, Inc. (HUMA)vs › | $80.30M | 0.48% | N/A | N/A | N/A |
| LENSAR Inc (LNSR)vs › | $82.29M | 0.03% | N/A | N/A | N/A |
| Cardiff Oncology, Inc. (CRDF)vs › | $82.47M | 0.01% | N/A | N/A | N/A |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO)vs › | $82.53M | 0.00% | N/A | N/A | N/A |
| ProMIS Neurosciences, Inc. (PMN)vs › | $82.59M | 0.00% | N/A | N/A | N/A |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $79.61M | 0.02% | N/A | N/A | N/A |
| Citius Oncology, Inc. (CTOR)vs › | $79.03M | 0.09% | N/A | N/A | N/A |
| vTv Therapeutics Inc. (VTVT)vs › | $78.59M | 0.00% | N/A | N/A | N/A |
Debt/Assets
0.3%
Debt/Equity
0.00
Current Ratio
8.75
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.29% |
| 2026-03-31 | 0.39% |
| 2025-12-31 | 0.43% |
| 2025-09-30 | 0.38% |
| 2025-06-30 | 0.61% |
| 2025-03-31 | 0.68% |
| 2024-12-31 | 0.35% |
| 2024-09-30 | 0.79% |
| 2024-06-30 | 0.31% |
| 2024-03-31 | 0.90% |
| 2023-12-31 | 0.33% |
| 2023-09-30 | 0.98% |
| 2023-06-30 | 1.05% |
| 2023-03-31 | 0.89% |
| 2022-12-31 | 0.92% |
| 2022-09-30 | 0.92% |
| 2022-06-30 | 0.95% |
| 2022-03-31 | 0.95% |
| 2021-12-31 | 0.95% |
| 2021-09-30 | 0.97% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.25% |
| 2020-09-30 | 0.05% |
| 2020-06-30 | 0.10% |
| 2020-03-31 | 0.17% |
| 2019-12-31 | 0.50% |
| 2019-09-30 | 0.31% |
| 2019-06-30 | 0.36% |
| 2019-03-31 | 0.30% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 2.13% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 16.76% |
| 2016-06-30 | 16.58% |
| 2016-03-31 | 42.08% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 36.81% |
| 2015-06-30 | 68.68% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 63.68% |
| 2014-06-30 | 56.27% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 37.94% |
| 2010-12-31 | 59.04% |
| 2010-09-30 | 18.60% |
| 2010-06-30 | 52.20% |
| 2010-03-31 | 49.05% |
| 2009-12-31 | 49.68% |
| 2009-09-30 | 31.64% |
| 2009-06-30 | 29.90% |
| 2009-03-31 | 28.20% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | 0.00% |
